|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bridges JF, Joy SM, Gallego G, Kudo M, Ye
SL, Han KH, Cheng AL and Blauvelt BM: Needs for hepatocellular
carcinoma control policy in the Asia-Pacific region. Asian Pac J
Cancer Prev. 12:2585–2591. 2011.PubMed/NCBI
|
|
3
|
Sherman M: Hepatocellular carcinoma:
epidemiology, surveillance and diagnosis. Semin Liver Dis. 30:3–16.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olsen SK, Brown RS and Siegel AB:
Hepatocellular carcinoma: review of current treatment with a focus
on targeted molecular therapies. Therap Adv Gastroenterol. 3:55–66.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
EI-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davila JA, Duan Z, McGlynn KA and El-Serag
HB: Utilization and outcomes of palliative therapy for
hepatocellular carcinoma: a population-based study in the United
States. J Clin Gastroenterol. 46:71–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Riedl SJ and Salvesen GS: The apoptosome:
signalling platform of cell death. Nat Rev Mol Cell Biol.
8:405–413. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fabregat I, Roncero C and Fernández M:
Survival and apoptosis: a dysregulated balance in liver cancer.
Liver Int. 27:155–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fransvea E, Angelotti U, Antonaci S and
Giannelli G: Blocking transforming growth factor-beta up-regulates
E-cadherin and reduces migration and invasion of hepatocellular
carcinoma cells. Hepatology. 47:1557–1566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hussain SP, Schwank J, Staib F, Wang XW
and Harris CC: TP53 mutations and hepatocellular carcinoma:
insights into the etiology and pathogenesis of liver cancer.
Oncogene. 26:2166–2176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Normile D: Asian medicine. The new face of
traditional Chinese medicine. Science. 299:188–190. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoon SB, Lee YJ, Park SK, Kim HC, Bae H,
Kim HM, Ko SG, Choi HY, Oh MS and Park W: Anti-inflammatory effects
of Scutellaria baicalensis water extract on LPS-activated
RAW 264.7 macrophages. J Ethnopharmacol. 125:286–290. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li-Weber M: New therapeutic aspects of
flavones: the anticancer properties of Scutellaria and its
main active constituents Wogonin, Baicalein and Baicalin. Cancer
Treat Rev. 35:57–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Burnett BP, Jia Q, Zhao Y and Levy RM: A
medicinal extract of Scutellaria baicalensis and Acacia
catechu acts as a dual inhibitor of cyclooxygenase and
5-lipoxygenase to reduce inflammation. J Med Food. 10:442–451.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Q, Wang J, Zou MJ, Hu R, Zhao L,
Qiang L, Rong JJ, You QD and Guo QL: Wogonin potentiates the
antitumor effects of low dose 5-fluorouracil against gastric cancer
through induction of apoptosis by down-regulation of NF-kappaB and
regulation of its metabolism. Toxicol Lett. 197:201–210. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enomoto R, Koshiba C, Suzuki C and Lee E:
Wogonin potentiates the antitumor action of etoposide and
ameliorates its adverse effects. Cancer Chemother Pharmacol.
67:1063–1072. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Lin G and Zuo Z: Pharmacological
effects and pharmacokinetics properties of Radix
Scutellariae and its bioactive flavones. Biopharm Drug Dispos.
32:427–445. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang YZ, Tang YZ and Liu YH: Wogonoside
displays anti-inflammatory effects through modulating inflammatory
mediator expression using RAW264.7 cells. J Ethnopharmacol.
148:271–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Zou M, Hu C, Qin Y, Song X, Lu N
and Guo Q: Wogonoside induces autophagy in MDA-MB-231 cells by
regulating MAPK-mTOR pathway. Food Chem Toxicol. 51:53–60. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Hui H, Yang H, Zhao K, Qin Y, Gu
C, Wang X, Lu N and Guo Q: Wogonoside induces cell cycle arrest and
differentiation by affecting expression and subcellular
localization of PLSCR1 in AMl cells. Blood. 121:3682–3691. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Lu N, Ling Y, Gao Y, Wang L, Sun
Y, Qi Q, Feng F, Liu W, Liu W, You Q and Guo Q: Wogonoside inhibits
lipopolysaccharide-induced angiogenesis in vitro and in vivo via
toll-like receptor 4 signal transduction. Toxicology. 259:10–17.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chow SE, Chang YL, Chuang SF and Wang JS:
Wogonin induced apoptosis in human nasopharyngeal carcinoma cells
by targeting GSK-3β and Δ Np63. Cancer Chemother Pharmacol.
68:835–845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baumann S, Fas SC, Giaisi M, Müller WW,
Merling A, Gülow K, Edler L, Krammer PH and Li-Weber M: Wogonin
preferentially kills malignant lymphocytes and suppresses T-cell
tumor growth by inducing PLCgamma1-and Ca2+-dependent apoptosis.
Blood. 111:2354–2363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roy M, Chakraborty S, Siddiqi M and
Bhattacharya RK: Induction of apoptosis in tumor cells by natural
phenolic compounds. Asian Pac J Cancer Prev. 3:61–67.
2002.PubMed/NCBI
|
|
25
|
Dang YM, Huang G, Chen YR, Dang ZF, Chen
C, Liu FL, Guo YF and Xie XD: Sulforaphane inhibits the
proliferation of the BIU87 bladder cancer cell line via IGFBP-3
elevation. Asian Pac J Cancer Prev. 15:1517–1520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu J, Liu H, Lei J, Tan W, Hu X and Zou G:
Antitumor activity of chloroform fraction of Scutellaria
barbata and its active constituents. Phytother Res. 21:817–822.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guicciardi ME and Gores GJ: Apoptosis: a
mechanism of acute and chronic liver injury. Gut. 54:1024–1033.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Steinbach JP and Weller M: Apoptosis in
Gliomas: Molecular Mechanisms and Therapeutic Implications. J
Neurooncol. 70:247–256. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Korsmeyer SJ: BCL-2 gene family and the
regulation of programmed cell death. Cancer Res. 59:(Suppl 7).
1693–1700. 1999.
|
|
31
|
Chung H, Jung YM, Shin DH, Lee JY, Oh MY,
Kim HJ, Jang KS, Jeon SJ, Son KH and Kong G: Anticancer effects of
wogonin in both estrogen receptor-positive and -negative human
breast cancer cell lines in vitro and in nude mice xenografts. Int
J Cancer. 122:816–822. 2008. View Article : Google Scholar : PubMed/NCBI
|
